Disproportionate Supression of Dehydroepiandrosterone Sulfate (DHEAS) in Treated Patients with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Serum concentrations of dehydroepiandrosterone sulfate (DHEAS) were measured in 28 patients (18 females, 10 males) with congenital adrenal hyperplasia due to 21-hydroxylase deficiency who were treated with oral hydrocortisone (non-salt losers) or hydrocortisone and 9-alpha-fluorohydrocortisone (salt-losers). Adequacy of therapy was assessed by clinical findings, determination of bone age, urinary excretion of 17-ketosteroids, and serum concentration of 17-hydroxyprogesterone. These allowed the separation of patients into three groups: poorly controlled, adequately controlled and overtreated. Individual values for serum levels of DHEAS were compared to mean normal values for age. In the adequately controlled and overtreated patients, mean serum concentrations of DHEAS were significantly lower than normal values for age (P less than 0.05). In the poorly treated patients, the mean serum concentration of DHEAS was not significantly different from normal values for age (P = 0.50). These data indicate that the serum concentration of DHEAS is overly suppressed in treated patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. This finding suggests that measurement of the serum levels of DHEAS has limited value in assessing the adequacy of therapy in this disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, DHEAS is a poor biomarker of 21OHD control, which can be paradoxically low in poorly controlled classic 21OHD patients (12, 29).”
From 24-Hour Profiles of 11-Oxygenated C19 Steroids and Δ5-Steroid Sulfates during Oral and Continuous Subcutaneous Glucocorticoids in 21-Hydroxylase Deficiency (2021) · cites this paper as [29]
Citations
Cites
An Introduction to Statistical Analysis.
Cochran, W. G., Dixon, W. J., & Massey, F. J. (1957) · Journal of the American Statistical Association · doi:10.2307/2280909 · Cited by 955
DREKTER, I. J., HEISLER, A., SCISM, G. R., STERN, S., PEARSON, S., & McGAVACK, T. H. (1952) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-12-1-55 · Cited by 385
PERETTI, E. D., & FOREST, M. G. (1978) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-47-3-572 · Cited by 211 · cited 1×
“Because secretion of DHEAS is age dependent (8, 15, 23), its role in the management of patients with CAH cannot be quantitated unless appropriate age-matched control values are applied.”
BackgroundReiter, E. O., Fuldauer, V. G., & Root, A. W. (1977) · The Journal of Pediatrics · doi:10.1016/s0022-3476(77)81244-4 · Cited by 173 · cited 2×
“ticoids has been observed in various pathologic (7,29) and experimental (20) conditions, as well as during normal development (21, 23, 28).”
Background24-Hour Secretory Pattern of Dehydroisoandrosterone and Dehydroisoandrosterone Sulfate
ROSENFELD, R. S., ROSENBERG, B. J., FUKUSHIMA, D. K., & HELLMAN, L. (1975) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-40-5-850 · Cited by 171 · cited 1×
“Moreover, as DHEAS has a long half-life (24, 26), its concentration in serum is less susceptible to diurnal variations (25).”
BackgroundAdrenarche: Changing Adrenal Response to Adrenocorticotropin*
RICH, B. H., ROSENFIELD, R. L., LUCKY, A. W., HELKE, J. C., & OTTO, P. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-52-6-1129 · Cited by 154 · cited 2×
“The existence of such a hormone, however, has been challenged and alternative explanations have been suggested (2, 22).”
BackgroundDehydroepiandrosterone Sulfate (DS) Levels, a Rapid Test for Abnormal Adrenal Androgen Secretion
KORTH-SCHUTZ, S., LEVINE, L. S., & NEW, M. I. (1976) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-42-6-1005 · Cited by 113 · cited 1×
“Because secretion of DHEAS is age dependent (8, 15, 23), its role in the management of patients with CAH cannot be quantitated unless appropriate age-matched control values are applied.”
BackgroundRadioimmunoassay of Plasma 17-Hydroxyprogesterone
ABRAHAM, G. E., SWERDLOFF, R. S., TULCHINSKY, D., HOPPER, K., & ODELL, W. D. (1971) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-33-1-42 · Cited by 111 · cited 1×
“Serum levels of 17-OHP were measured by radioirnmunoassay (1).”
MethodThe Adrenarche: Prolactin, Gonadotropins, Adrenal Androgens, and Cortisol
PARKER, L. N., SACK, J., FISHER, D. A., & ODELL, W. D. (1978) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-46-3-396 · Cited by 102
Experience with long-term therapy in congenital adrenal hyperplasia
Brook, C. G. D., ZACHMANN, M., Prader, A., & Mürset, G. (1974) · The Journal of Pediatrics · doi:10.1016/s0022-3476(74)80277-5 · Cited by 94 · cited 1×
“( 1 ) normal linear growth; (2) normal bone age and normal rate of advancement of bone age; (3) no evidence of ongoing inappropriate virilization such as premature appearance of pubic hair or phallic or clitoral enlargement; (4) urinary 17 ketosteroids at or below age-related upper limits (14); (5) serum concentration…”
Background
Cited by
Turcu, A. F., Nanba, A. T., Chomic, R., Upadhyay, S. K., Giordano, T. J., Shields, J. J., Merke, D. P., Rainey, W. E., & Auchus, R. J. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1181 · Cited by 231
11-Oxygenated androgens in health and disease
Turcu, A. F., Rege, J., Auchus, R. J., & Rainey, W. E. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0336-x · Cited by 217
Congenital Adrenal Hyperplasia
Witchel, S. F. (2017) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2017.04.001 · Cited by 184
Congenital Adrenal Hyperplasia
Witchel, S. F., & Azziz, R. (2011) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2010.10.001 · Cited by 159
Gazarian, M., Cowell, C., Bonney, M., & Grigor, W. G. (1994) · European Journal of Pediatrics · doi:10.1007/bf01972967 · Cited by 140
Metadata
- Authors
- Rezvani, I., Garibaldi, L. R., Digeorge, A. M., & Artman, H. G.
- Affiliations
- St. Christopher's Hospital for Children (US)
- ORCID
- Garibaldi, Luigi R
- Venue
- Pediatric Research
- Published
- 1983-02
- Volume
- 17
- Issue
- 2
- Pages
- 131-134
- ISSN
- 0031-3998 (ISSN-L)
- 1530-0447
- OpenAlex
- W2022883373
- Cited by
- 33
- References
- 23
- Citations by year
- 2026: 2 · 2022: 2 · 2021: 2 · 2020: 2 · 2019: 2 · 2018: 2 · 2017: 3 · 2016: 2 · 2015: 1 · 2014: 3 · 2013: 1
- FWCI
- 0.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Pediatric Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- dehydroepiandrosterone sulfate, congenital adrenal hyperplasia, 21-hydroxylase deficiency, hydrocortisone therapy, 9-alpha-fluorohydrocortisone, 17-hydroxyprogesterone, bone age, urinary 17-ketosteroids, overtreatment
- MeSH terms
- Adolescent, Adrenal Hyperplasia, Congenital, Age Factors, Child, Dehydroepiandrosterone, Female, Fludrocortisone, Follow-Up Studies, Humans, Hydrocortisone, Mixed Function Oxygenases, Male, Dehydroepiandrosterone Sulfate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Disproportionate Supression of Dehydroepiandrosterone Sulfate (DHEAS) in Treated Patients with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency. https://app.cochat.ai/papers/10.1203/00006450-198302000-00010
- The paper
- Rezvani, I., Garibaldi, L. R., Digeorge, A. M., & Artman, H. G. (1983). Disproportionate Supression of Dehydroepiandrosterone Sulfate (DHEAS) in Treated Patients with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency. Pediatric Research. https://doi.org/10.1203/00006450-198302000-00010
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.